MiRNA analysis in serum.

RIF indices of all six miRNAs in patient 3.

Xue Chen (127892)
Jing Chen (4762)
Xinjuan Liu (420183)
Zihao Guo (420184)
Xiaoxin Sun (532916)
Jie Zhang (64655)

June 2014

miR-21, miR-200b, miR-200a, miR-146a, miR-155, and miR-221 activities are shown in A–F, respectiv...

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Loosen, Sven H.
Lurje, Georg
Wiltberger, Georg
Vucur, Mihael
Koch, Alexander
Kather, Jakob N.
Paffenholz, Pia
Tacke, Frank
Ulmer, Florian T.
Trautwein, Christian
Luedde, Tom
Neumann, Ulf P.
Roderburg, Christoph

January 2019

Objectives Cholangiocarcinoma (CCA) represents the second most common primary hepatic malignancy. De...

Differential expression of serum miRNA levels in HCC and CLD patients.

Tarek K. Motawi (793607)
Olfat G. Shaker (713168)
Shohda A. El-Maraghy (674090)
Mahmoud A. Senousy (793608)

September 2015

The box represents the 25%-75% percentiles; the line inside the box represents the median and the...

MiRNA analysis in serum.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Serum validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 40) and cho...

Serum miRNA analysis.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...

Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Bernuzzi, F.
Marabita, F.
Lleo, A.
Carbone, M.
Mirolo, M.
Marzioni, M.
Alpini, G.
Alvaro, D.
Boberg, K. M.
Locati, M.
Torzilli, G.
Rimassa, L.
Piscaglia, Fabio
X. S., He
Bowlus, C. L.
Yang, G. X.
Gershwin, M. E.
Invernizzi, P.

January 2016

The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...

MiRNA analysis in bile.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Bile validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 52), cholang...

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma

Voigtländer Torsten
Gupta Shashi K.
Thum Sabrina
Fendrich Jasmin
Manns Michael P.
Lankisch Tim O.
Thum Thomas

October 2015

Patients with primary sclerosing cholangitis (PSC) are at high risk for the development of cholangio...

Bile miRNA analysis.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...

Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Bernuzzi, Francesca
Marabita, Francesco
Lleo, Ana
Carbone, Marco
Mirolo, Massimiliano
MARZIONI, MARCO
Alpini, Gianfranco
Alvaro, Domenico
Muri Boberg, Kirsten
Locati, Massimo
Torzilli, Guido
Rimassa, Lorenza
Piscaglia, Fabio
He, Xiao Song
Bowlus, Christopher L
Yang, Guo Xiang
Eric Gershwin, M
Invernizzi, Pietro

January 2016

The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...

Serum levels of miR-122, miR-192, miR-29b, and miR-155 are elevated in patients with cholangiocarcinoma.

Sven H. Loosen (5866946)
Georg Lurje (5059535)
Georg Wiltberger (533489)
Mihael Vucur (180119)
Alexander Koch (77280)
Jakob N. Kather (6240275)
Pia Paffenholz (6240278)
Frank Tacke (170575)
Florian T. Ulmer (6240281)
Christian Trautwein (64353)
Tom Luedde (180139)
Ulf P. Neumann (5059544)
Christoph Roderburg (180091)

January 2019

Circulating levels of miR-122 (A), miR-192 (B), miR-29b (C) and miR-155 (D) are significantly elevat...

Clinical features, demographics and laboratory values of the patient cohorts.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

The aforementioned parameters are presented in Table 2 (Serum). Patients with primary sclerosing ...

Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.

Hochberg, Jessica T
Sohal, Aalam
Handa, Priya
Maliken, Bryan D
Kim, Take-Kyun
Wang, Kai
Gochanour, Eric
Li, Yu
Rose, J Bart
Nelson, James E
Lindor, Keith D
LaRusso, Nicholas F
Kowdley, Kris V

June 2023

BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver ...

RIF indices of all six miRNAs in patient 2.

Xue Chen (127892)
Jing Chen (4762)
Xinjuan Liu (420183)
Zihao Guo (420184)
Xiaoxin Sun (532916)
Jie Zhang (64655)

June 2014

miR-21, miR-200b, miR-200a, miR-146a, miR-155, and miR-221 activities are shown in A–F, respectiv...

Serum miRNAs overexpressed in HCC patients with PVTT in comparison with no PVTT.

Liping Zhuang (459677)
Litao Xu (556562)
Peng Wang (34436)
Zhiqiang Meng (369515)

February 2015

Serum miRNAs overexpressed in HCC patients with PVTT in comparison with no PVTT.</p

RIF indices of all six miRNAs in patient 3.

Xue Chen (127892)
Jing Chen (4762)
Xinjuan Liu (420183)
Zihao Guo (420184)
Xiaoxin Sun (532916)
Jie Zhang (64655)

June 2014

miR-21, miR-200b, miR-200a, miR-146a, miR-155, and miR-221 activities are shown in A–F, respectiv...

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Loosen, Sven H.
Lurje, Georg
Wiltberger, Georg
Vucur, Mihael
Koch, Alexander
Kather, Jakob N.
Paffenholz, Pia
Tacke, Frank
Ulmer, Florian T.
Trautwein, Christian
Luedde, Tom
Neumann, Ulf P.
Roderburg, Christoph

January 2019

Objectives Cholangiocarcinoma (CCA) represents the second most common primary hepatic malignancy. De...

Differential expression of serum miRNA levels in HCC and CLD patients.

Tarek K. Motawi (793607)
Olfat G. Shaker (713168)
Shohda A. El-Maraghy (674090)
Mahmoud A. Senousy (793608)

September 2015

The box represents the 25%-75% percentiles; the line inside the box represents the median and the...

MiRNA analysis in serum.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Serum validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 40) and cho...

Serum miRNA analysis.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...

Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Bernuzzi, F.
Marabita, F.
Lleo, A.
Carbone, M.
Mirolo, M.
Marzioni, M.
Alpini, G.
Alvaro, D.
Boberg, K. M.
Locati, M.
Torzilli, G.
Rimassa, L.
Piscaglia, Fabio
X. S., He
Bowlus, C. L.
Yang, G. X.
Gershwin, M. E.
Invernizzi, P.

January 2016

The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...

MiRNA analysis in bile.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Bile validation analysis for patients with primary sclerosing cholangitis (PSC) (n = 52), cholang...

MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma

Voigtländer Torsten
Gupta Shashi K.
Thum Sabrina
Fendrich Jasmin
Manns Michael P.
Lankisch Tim O.
Thum Thomas

October 2015

Patients with primary sclerosing cholangitis (PSC) are at high risk for the development of cholangio...

Bile miRNA analysis.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

Sensitivity and specificity to distinguish between patients with primary sclerosing cholangitis (...

Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma

Bernuzzi, Francesca
Marabita, Francesco
Lleo, Ana
Carbone, Marco
Mirolo, Massimiliano
MARZIONI, MARCO
Alpini, Gianfranco
Alvaro, Domenico
Muri Boberg, Kirsten
Locati, Massimo
Torzilli, Guido
Rimassa, Lorenza
Piscaglia, Fabio
He, Xiao Song
Bowlus, Christopher L
Yang, Guo Xiang
Eric Gershwin, M
Invernizzi, Pietro

January 2016

The diagnosis of primary sclerosing cholangitis (PSC) is difficult due to the lack of sensitive and ...

Serum levels of miR-122, miR-192, miR-29b, and miR-155 are elevated in patients with cholangiocarcinoma.

Sven H. Loosen (5866946)
Georg Lurje (5059535)
Georg Wiltberger (533489)
Mihael Vucur (180119)
Alexander Koch (77280)
Jakob N. Kather (6240275)
Pia Paffenholz (6240278)
Frank Tacke (170575)
Florian T. Ulmer (6240281)
Christian Trautwein (64353)
Tom Luedde (180139)
Ulf P. Neumann (5059544)
Christoph Roderburg (180091)

January 2019

Circulating levels of miR-122 (A), miR-192 (B), miR-29b (C) and miR-155 (D) are significantly elevat...

Clinical features, demographics and laboratory values of the patient cohorts.

Torsten Voigtländer (563573)
Shashi K. Gupta (802718)
Sabrina Thum (802719)
Jasmin Fendrich (802720)
Michael P. Manns (92947)
Tim O. Lankisch (563575)
Thomas Thum (66741)

October 2015

The aforementioned parameters are presented in Table 2 (Serum). Patients with primary sclerosing ...

Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid.

Hochberg, Jessica T
Sohal, Aalam
Handa, Priya
Maliken, Bryan D
Kim, Take-Kyun
Wang, Kai
Gochanour, Eric
Li, Yu
Rose, J Bart
Nelson, James E
Lindor, Keith D
LaRusso, Nicholas F
Kowdley, Kris V

June 2023

BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is a chronic, progressive cholestatic liver ...

RIF indices of all six miRNAs in patient 2.

Xue Chen (127892)
Jing Chen (4762)
Xinjuan Liu (420183)
Zihao Guo (420184)
Xiaoxin Sun (532916)
Jie Zhang (64655)

June 2014

miR-21, miR-200b, miR-200a, miR-146a, miR-155, and miR-221 activities are shown in A–F, respectiv...

Serum miRNAs overexpressed in HCC patients with PVTT in comparison with no PVTT.

Liping Zhuang (459677)
Litao Xu (556562)
Peng Wang (34436)
Zhiqiang Meng (369515)

February 2015

Serum miRNAs overexpressed in HCC patients with PVTT in comparison with no PVTT.</p

RIF indices of all six miRNAs in patient 3.

Xue Chen (127892)
Jing Chen (4762)
Xinjuan Liu (420183)
Zihao Guo (420184)
Xiaoxin Sun (532916)
Jie Zhang (64655)

June 2014

miR-21, miR-200b, miR-200a, miR-146a, miR-155, and miR-221 activities are shown in A–F, respectiv...

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma

Loosen, Sven H.
Lurje, Georg
Wiltberger, Georg
Vucur, Mihael
Koch, Alexander
Kather, Jakob N.
Paffenholz, Pia
Tacke, Frank
Ulmer, Florian T.
Trautwein, Christian
Luedde, Tom
Neumann, Ulf P.
Roderburg, Christoph

January 2019

Objectives Cholangiocarcinoma (CCA) represents the second most common primary hepatic malignancy. De...

Differential expression of serum miRNA levels in HCC and CLD patients.

Tarek K. Motawi (793607)
Olfat G. Shaker (713168)
Shohda A. El-Maraghy (674090)
Mahmoud A. Senousy (793608)

September 2015

The box represents the 25%-75% percentiles; the line inside the box represents the median and the...

MiRNA analysis in serum.

Abstract

Extracted data

Related items

Related items